Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?

Sun, Chen

Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer? [electronic resource] - World journal of gastroenterology Sep 2012 - 4944-58 p. digital

Publication Type: Journal Article; Meta-Analysis; Review

2219-2840

10.3748/wjg.v18.i35.4944 doi


Adult
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Chi-Square Distribution
Deoxycytidine--administration & dosage
Disease-Free Survival
Female
Humans
Male
Middle Aged
Odds Ratio
Pancreatic Neoplasms--drug therapy
Survival Analysis
Time Factors
Treatment Outcome
Young Adult
Gemcitabine